Get started
Live feed
·
SECFilingvia Quantisnow
NRX Pharmaceuticals Inc. logo

NRXP: NRX Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow AI summary

FDA approved NRx's ANDA for Preservative-Free Ketamine ahead of the Nov 10, 2026 GDUFA goal date.

Historical context for NRXP

Across the 27 sessions after earlier NRXP headlines, the stock closed higher 15 times and lower 9 times, with a median move of 2.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

NRXP close-to-close change in the session after earlier headlines
SessionEarlier headlineNRXPSPY
Oct 30, 2026NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Dateand 1 other headline that session-14.7%-1.8%
Oct 19, 2026NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine+1.2%+0.4%
Oct 15, 2026NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine+4.6%+0.3%
Sep 30, 2026NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression+0.0%-0.2%
Sep 15, 2026NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine-2.6%-0.5%
Sep 14, 2026GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)+2.6%-0.4%
Quantisnow market dataNASDAQ
NRX Pharmaceuticals Inc. logo
NRXP
NRX Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2017
Get push alerts for NRXP

Follow NRXP and get a push notification the moment its next story breaks.

Full NRXP profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NRXP (NRX Pharmaceuticals Inc.) and more on Quantisnow.